Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity.
Riskiest Junk Bonds Shunned in Europe on Rising Risk of DefaultTesla’s Market Story Is All About Growth.
That’s Now in QuestionXcel Energy to Cut Power in Parts of Colorado Amid High WindsDo Kwon, Terraform Labs Found Liable for Fraud in SEC TrialFrom Skydiving to Wine Tasting, New York Readies for the EclipseWarner Music Says It Will Not Bid for French Label BelieveMacquarie Rules Out Buying Heathrow Stake, Telegraph ReportsMongolia’s Livestock Are Being Killed by Winter Climate DisastersSenator Menendez, Wife Want Luxury Lifestyle Barred at TrialXcel Energy to Cut Power in Parts of Colorado Amid...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy to be covered by US Medicare for heart disease patientsExplore stories from Atlantic Canada.
Read more »
Medicare can pay for obesity drugs like Wegovy in certain heart patientsMedicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future...
Read more »
Germany's health insurance could cover Wegovy for strokes, heart conditions, agency saysExplore stories from Atlantic Canada.
Read more »
Wegovy gains Medicare, Medicaid coverage for heart benefitsNovo Nordisk's (NVO) weight-loss medication, Wegovy, will now be covered by Medicare and Medicaid. This decision comes in light of the drug's demonstrated...
Read more »
Novo ready to seek German insurance coverage of Wegovy for heart useExplore stories from Atlantic Canada.
Read more »
Novo ready to seek German insurance coverage of Wegovy for heart useExplore stories from Atlantic Canada.
Read more »